Industry Posters (Non-CE) 

Final Results from a Long-Term Open Label Extension Study (Up to 4 Years): Tolerability of Fenfluramine and Global Functioning of Pediatric and Adult Patients with Dravet or Lennox-Gastaut Syndromes

Presentation Date/Time: Sunday, March 22 from 5:45-6 PM
Presented By: Mercedes Martin, MSN, FNP-C, Medical Lead, Rare Epilepsies, UCB, Inc

Click here to view the poster.